Elisabet Borsheim
Concepts (292)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Burns | 13 | 2019 | 165 | 3.430 |
Why?
| Muscle, Skeletal | 23 | 2019 | 769 | 3.300 |
Why?
| Muscle Proteins | 13 | 2019 | 316 | 2.170 |
Why?
| Mitochondria, Muscle | 5 | 2019 | 38 | 1.800 |
Why?
| Insulin Resistance | 7 | 2020 | 255 | 1.670 |
Why?
| Oxygen Consumption | 8 | 2019 | 188 | 1.530 |
Why?
| Exercise | 12 | 2020 | 493 | 1.500 |
Why?
| Insulin | 12 | 2020 | 453 | 1.340 |
Why?
| Blood Glucose | 9 | 2020 | 432 | 1.130 |
Why?
| Energy Metabolism | 10 | 2019 | 282 | 1.090 |
Why?
| Amino Acids, Essential | 5 | 2008 | 133 | 1.070 |
Why?
| Triglycerides | 7 | 2020 | 152 | 0.990 |
Why?
| Amino Acids | 6 | 2015 | 363 | 0.970 |
Why?
| Adipose Tissue | 4 | 2019 | 188 | 0.910 |
Why?
| Maternal Nutritional Physiological Phenomena | 2 | 2020 | 55 | 0.800 |
Why?
| Sulfoxides | 1 | 2020 | 18 | 0.720 |
Why?
| Isothiocyanates | 1 | 2020 | 17 | 0.720 |
Why?
| Adrenergic beta-Antagonists | 3 | 2014 | 106 | 0.710 |
Why?
| NF-E2-Related Factor 2 | 1 | 2020 | 40 | 0.710 |
Why?
| Body Composition | 5 | 2019 | 320 | 0.700 |
Why?
| Dietary Proteins | 2 | 2020 | 240 | 0.690 |
Why?
| Amino Acids, Branched-Chain | 1 | 2020 | 36 | 0.680 |
Why?
| Obesity | 5 | 2020 | 1096 | 0.680 |
Why?
| Liver | 3 | 2020 | 1106 | 0.670 |
Why?
| Indocyanine Green | 2 | 2019 | 34 | 0.660 |
Why?
| Blood Cells | 1 | 2019 | 43 | 0.660 |
Why?
| Diabetes, Gestational | 1 | 2019 | 51 | 0.640 |
Why?
| Muscle Fibers, Skeletal | 1 | 2019 | 63 | 0.620 |
Why?
| Adipose Tissue, Brown | 5 | 2016 | 40 | 0.610 |
Why?
| Humans | 53 | 2020 | 49929 | 0.550 |
Why?
| Female | 36 | 2020 | 26576 | 0.540 |
Why?
| Male | 39 | 2020 | 25454 | 0.520 |
Why?
| Leucine | 5 | 2019 | 115 | 0.520 |
Why?
| Hypoglycemic Agents | 2 | 2014 | 169 | 0.510 |
Why?
| Autonomic Nervous System | 1 | 2016 | 57 | 0.510 |
Why?
| Electron Transport Complex II | 1 | 2015 | 7 | 0.500 |
Why?
| Electron Transport Complex I | 1 | 2015 | 22 | 0.500 |
Why?
| Oxidative Phosphorylation | 1 | 2015 | 40 | 0.490 |
Why?
| Adult | 25 | 2020 | 13356 | 0.490 |
Why?
| Androgens | 1 | 2014 | 67 | 0.470 |
Why?
| Anabolic Agents | 1 | 2014 | 37 | 0.470 |
Why?
| Muscles | 1 | 2014 | 101 | 0.450 |
Why?
| Down-Regulation | 1 | 2015 | 342 | 0.450 |
Why?
| Phenylalanine | 6 | 2014 | 127 | 0.450 |
Why?
| Dietary Carbohydrates | 2 | 2004 | 89 | 0.440 |
Why?
| Diphosphonates | 1 | 2014 | 90 | 0.440 |
Why?
| Body Mass Index | 4 | 2020 | 648 | 0.430 |
Why?
| Physical Exertion | 3 | 1998 | 44 | 0.420 |
Why?
| Dietary Supplements | 6 | 2019 | 437 | 0.420 |
Why?
| Time Factors | 11 | 2020 | 2891 | 0.420 |
Why?
| Aging | 3 | 2015 | 669 | 0.420 |
Why?
| Fatty Acids, Nonesterified | 4 | 2020 | 38 | 0.410 |
Why?
| Arginine | 3 | 2008 | 178 | 0.400 |
Why?
| Child | 11 | 2020 | 6849 | 0.370 |
Why?
| Adolescent | 11 | 2020 | 6417 | 0.370 |
Why?
| Pregnancy | 8 | 2020 | 2468 | 0.360 |
Why?
| Lipid Metabolism | 3 | 2016 | 175 | 0.340 |
Why?
| Glucose Intolerance | 3 | 2020 | 27 | 0.330 |
Why?
| Receptors, Adrenergic, beta | 2 | 2000 | 42 | 0.330 |
Why?
| Hypertriglyceridemia | 1 | 2008 | 14 | 0.320 |
Why?
| Child, Preschool | 8 | 2020 | 3879 | 0.310 |
Why?
| Adiposity | 2 | 2020 | 129 | 0.310 |
Why?
| Fatty Acids | 3 | 2004 | 143 | 0.310 |
Why?
| Muscle Strength | 2 | 2014 | 125 | 0.310 |
Why?
| Palmitic Acid | 2 | 2006 | 22 | 0.290 |
Why?
| Proteins | 1 | 2010 | 347 | 0.280 |
Why?
| Cohort Studies | 4 | 2020 | 1403 | 0.280 |
Why?
| Oleic Acid | 1 | 2006 | 5 | 0.280 |
Why?
| Resistance Training | 2 | 2017 | 92 | 0.250 |
Why?
| Protein Biosynthesis | 4 | 2017 | 252 | 0.250 |
Why?
| Brain Injuries | 1 | 2007 | 159 | 0.250 |
Why?
| Renal Dialysis | 2 | 2005 | 170 | 0.240 |
Why?
| Case-Control Studies | 4 | 2019 | 1129 | 0.240 |
Why?
| Adaptation, Physiological | 2 | 2014 | 92 | 0.230 |
Why?
| Weight Lifting | 1 | 2004 | 29 | 0.230 |
Why?
| Mitochondria | 3 | 2016 | 395 | 0.230 |
Why?
| Propranolol | 4 | 2014 | 78 | 0.220 |
Why?
| Milk Proteins | 1 | 2004 | 77 | 0.220 |
Why?
| Pregnant Women | 2 | 2020 | 74 | 0.210 |
Why?
| Lipolysis | 2 | 2012 | 11 | 0.200 |
Why?
| Organ Size | 2 | 2019 | 223 | 0.190 |
Why?
| Gestational Age | 2 | 2019 | 386 | 0.190 |
Why?
| Weight Gain | 2 | 2019 | 230 | 0.180 |
Why?
| Swine | 3 | 2015 | 396 | 0.180 |
Why?
| Biopsy | 3 | 2014 | 591 | 0.180 |
Why?
| Physical Fitness | 1 | 2020 | 54 | 0.180 |
Why?
| Adiponectin | 1 | 2020 | 44 | 0.180 |
Why?
| Fibroblast Growth Factors | 1 | 2020 | 45 | 0.180 |
Why?
| Homeostasis | 2 | 2019 | 202 | 0.180 |
Why?
| Maternal-Fetal Exchange | 1 | 2020 | 43 | 0.170 |
Why?
| Hydrocortisone | 5 | 2020 | 107 | 0.170 |
Why?
| Meals | 1 | 2020 | 54 | 0.170 |
Why?
| Physical Endurance | 3 | 2004 | 30 | 0.170 |
Why?
| Oxidative Phosphorylation Coupling Factors | 1 | 2019 | 6 | 0.170 |
Why?
| Sarcopenia | 1 | 2020 | 91 | 0.170 |
Why?
| Schools | 1 | 2020 | 162 | 0.170 |
Why?
| Eating | 1 | 2020 | 157 | 0.170 |
Why?
| Burn Units | 1 | 2019 | 9 | 0.170 |
Why?
| Liver Failure | 1 | 2019 | 21 | 0.160 |
Why?
| Lipoproteins, VLDL | 1 | 1999 | 9 | 0.160 |
Why?
| Models, Biological | 3 | 2019 | 719 | 0.160 |
Why?
| Young Adult | 7 | 2020 | 4031 | 0.160 |
Why?
| Kinetics | 4 | 2016 | 632 | 0.160 |
Why?
| Feeding Behavior | 1 | 2020 | 177 | 0.160 |
Why?
| Adipose Tissue, White | 2 | 2016 | 34 | 0.160 |
Why?
| Monocytes | 1 | 2019 | 131 | 0.160 |
Why?
| Animals | 9 | 2020 | 13100 | 0.150 |
Why?
| Receptors, Adrenergic | 1 | 1998 | 14 | 0.150 |
Why?
| Sympathetic Nervous System | 1 | 1998 | 19 | 0.150 |
Why?
| Exercise Therapy | 2 | 2020 | 93 | 0.150 |
Why?
| Age Factors | 2 | 2019 | 1092 | 0.150 |
Why?
| Heart Rate | 5 | 2007 | 299 | 0.150 |
Why?
| Cold Temperature | 2 | 2016 | 45 | 0.150 |
Why?
| Hepatocytes | 1 | 2019 | 179 | 0.150 |
Why?
| Arkansas | 2 | 2020 | 1990 | 0.150 |
Why?
| Ion Channels | 2 | 2015 | 74 | 0.150 |
Why?
| Mitochondrial Proteins | 2 | 2015 | 88 | 0.150 |
Why?
| Oxidation-Reduction | 4 | 2020 | 315 | 0.140 |
Why?
| Nitrogen Isotopes | 2 | 2010 | 35 | 0.140 |
Why?
| Blood Platelets | 1 | 2019 | 249 | 0.140 |
Why?
| Urea | 2 | 2010 | 77 | 0.140 |
Why?
| Carbon Isotopes | 4 | 2005 | 70 | 0.140 |
Why?
| Parents | 1 | 2019 | 320 | 0.140 |
Why?
| Patient Discharge | 1 | 2019 | 318 | 0.140 |
Why?
| Thermogenesis | 2 | 2014 | 24 | 0.140 |
Why?
| Carbohydrate Metabolism | 1 | 2016 | 26 | 0.130 |
Why?
| Human Growth Hormone | 2 | 2014 | 50 | 0.130 |
Why?
| Treatment Outcome | 3 | 2014 | 5178 | 0.130 |
Why?
| Oxidative Stress | 1 | 2020 | 759 | 0.130 |
Why?
| Proton Ionophores | 1 | 2015 | 3 | 0.130 |
Why?
| Uncoupling Agents | 1 | 2015 | 5 | 0.130 |
Why?
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2015 | 5 | 0.130 |
Why?
| Oligomycins | 1 | 2015 | 7 | 0.130 |
Why?
| Myofibrils | 1 | 2015 | 19 | 0.130 |
Why?
| Deuterium | 3 | 2005 | 43 | 0.120 |
Why?
| Infusions, Intravenous | 2 | 2013 | 212 | 0.120 |
Why?
| Hyperinsulinism | 1 | 2015 | 27 | 0.120 |
Why?
| Ethanol | 1 | 1998 | 335 | 0.120 |
Why?
| Aged | 4 | 2019 | 9449 | 0.120 |
Why?
| Nutritional Support | 1 | 2015 | 35 | 0.120 |
Why?
| Oxandrolone | 1 | 2014 | 10 | 0.120 |
Why?
| Quadriceps Muscle | 1 | 2015 | 46 | 0.120 |
Why?
| Ascorbic Acid | 1 | 2014 | 22 | 0.120 |
Why?
| Body Surface Area | 1 | 2014 | 26 | 0.120 |
Why?
| Vitamins | 1 | 2014 | 64 | 0.120 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2020 | 483 | 0.120 |
Why?
| Placebos | 1 | 2014 | 84 | 0.120 |
Why?
| Stress, Physiological | 1 | 2015 | 173 | 0.120 |
Why?
| Testosterone | 1 | 2014 | 137 | 0.120 |
Why?
| Predictive Value of Tests | 2 | 2015 | 907 | 0.120 |
Why?
| MAP Kinase Signaling System | 1 | 2014 | 118 | 0.120 |
Why?
| Cross-Over Studies | 3 | 2020 | 223 | 0.110 |
Why?
| Vitamin E | 1 | 2014 | 76 | 0.110 |
Why?
| Infant | 2 | 2020 | 3575 | 0.110 |
Why?
| Glucose | 1 | 2016 | 337 | 0.110 |
Why?
| Mitochondrial Diseases | 1 | 2014 | 42 | 0.110 |
Why?
| Metformin | 1 | 2014 | 63 | 0.110 |
Why?
| Area Under Curve | 2 | 2004 | 178 | 0.110 |
Why?
| Signal Transduction | 1 | 2020 | 1608 | 0.110 |
Why?
| Risk Factors | 2 | 2019 | 3605 | 0.110 |
Why?
| Norepinephrine | 3 | 2000 | 113 | 0.110 |
Why?
| Recombinant Proteins | 1 | 2014 | 482 | 0.110 |
Why?
| Cachexia | 1 | 2013 | 25 | 0.110 |
Why?
| Muscle Strength Dynamometer | 2 | 2014 | 12 | 0.110 |
Why?
| Absorptiometry, Photon | 2 | 2014 | 152 | 0.100 |
Why?
| Skin | 1 | 2015 | 415 | 0.100 |
Why?
| Fenofibrate | 1 | 2012 | 16 | 0.100 |
Why?
| PPAR alpha | 1 | 2012 | 56 | 0.100 |
Why?
| Rest | 2 | 2014 | 60 | 0.100 |
Why?
| Hyperglycemia | 1 | 2012 | 81 | 0.100 |
Why?
| Health Status | 1 | 2013 | 298 | 0.090 |
Why?
| Middle Aged | 4 | 2016 | 12293 | 0.090 |
Why?
| Alanine | 1 | 2010 | 41 | 0.090 |
Why?
| Mice | 1 | 2020 | 5658 | 0.090 |
Why?
| Nitrogen | 1 | 2010 | 67 | 0.090 |
Why?
| Extracellular Fluid | 2 | 2009 | 14 | 0.090 |
Why?
| Double-Blind Method | 2 | 2017 | 679 | 0.080 |
Why?
| Isoproterenol | 2 | 2000 | 56 | 0.080 |
Why?
| Hemodilution | 1 | 2009 | 7 | 0.080 |
Why?
| Cholesterol, VLDL | 1 | 2008 | 3 | 0.080 |
Why?
| Isotonic Solutions | 1 | 2009 | 17 | 0.080 |
Why?
| Regional Blood Flow | 2 | 2000 | 106 | 0.080 |
Why?
| Prospective Studies | 1 | 2015 | 2345 | 0.080 |
Why?
| Forearm | 1 | 2009 | 33 | 0.080 |
Why?
| Cholesterol | 1 | 2008 | 148 | 0.080 |
Why?
| Aged, 80 and over | 1 | 2015 | 3138 | 0.070 |
Why?
| Anesthesia, Inhalation | 1 | 2007 | 12 | 0.070 |
Why?
| Longitudinal Studies | 2 | 2020 | 693 | 0.070 |
Why?
| Isoflurane | 1 | 2007 | 14 | 0.070 |
Why?
| Reference Values | 2 | 1998 | 302 | 0.070 |
Why?
| Gait | 1 | 2008 | 85 | 0.070 |
Why?
| Anesthetics, Inhalation | 1 | 2007 | 32 | 0.070 |
Why?
| Sodium Chloride | 1 | 2007 | 56 | 0.070 |
Why?
| Lower Extremity | 1 | 2008 | 92 | 0.070 |
Why?
| Beverages | 1 | 2007 | 56 | 0.070 |
Why?
| Exercise Test | 2 | 2014 | 129 | 0.070 |
Why?
| Epinephrine | 2 | 1998 | 97 | 0.070 |
Why?
| Carbon Dioxide | 1 | 2006 | 94 | 0.070 |
Why?
| Microdialysis | 1 | 2005 | 18 | 0.070 |
Why?
| Intracellular Fluid | 1 | 2005 | 13 | 0.060 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 1 | 2005 | 60 | 0.060 |
Why?
| Cell Respiration | 2 | 2016 | 41 | 0.060 |
Why?
| Carnitine | 1 | 2005 | 61 | 0.060 |
Why?
| Creatine | 1 | 2004 | 38 | 0.060 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2005 | 326 | 0.060 |
Why?
| Skiing | 1 | 2004 | 2 | 0.060 |
Why?
| Endocrine System | 1 | 2004 | 16 | 0.060 |
Why?
| Sex Factors | 2 | 2004 | 692 | 0.060 |
Why?
| Immune System | 1 | 2004 | 43 | 0.060 |
Why?
| Eukaryotic Initiation Factor-2B | 1 | 2003 | 5 | 0.050 |
Why?
| Physical Education and Training | 1 | 2003 | 24 | 0.050 |
Why?
| Catecholamines | 2 | 2004 | 45 | 0.050 |
Why?
| Sports | 1 | 2003 | 40 | 0.050 |
Why?
| Diet | 1 | 2006 | 553 | 0.050 |
Why?
| Infant, Newborn | 2 | 2020 | 2729 | 0.050 |
Why?
| Hydralazine | 1 | 2000 | 4 | 0.040 |
Why?
| Body Fat Distribution | 1 | 2020 | 9 | 0.040 |
Why?
| Glycerol | 1 | 2000 | 15 | 0.040 |
Why?
| Polysomnography | 1 | 2020 | 70 | 0.040 |
Why?
| Osmolar Concentration | 2 | 2003 | 63 | 0.040 |
Why?
| Language | 1 | 2020 | 134 | 0.040 |
Why?
| Thiobarbituric Acid Reactive Substances | 1 | 1999 | 10 | 0.040 |
Why?
| Plethysmography | 1 | 2019 | 43 | 0.040 |
Why?
| Sleep | 1 | 2020 | 179 | 0.040 |
Why?
| Insulin-Like Growth Factor I | 1 | 2019 | 138 | 0.040 |
Why?
| Adrenergic beta-Agonists | 1 | 1998 | 41 | 0.040 |
Why?
| Bicycling | 1 | 1998 | 26 | 0.040 |
Why?
| Feasibility Studies | 1 | 2020 | 382 | 0.040 |
Why?
| Community-Based Participatory Research | 1 | 2020 | 197 | 0.040 |
Why?
| Atenolol | 1 | 1998 | 14 | 0.040 |
Why?
| Xenon Radioisotopes | 1 | 1998 | 2 | 0.040 |
Why?
| Pilot Projects | 1 | 2020 | 702 | 0.040 |
Why?
| Carbon Radioisotopes | 1 | 1998 | 53 | 0.040 |
Why?
| Hemoglobins | 2 | 2009 | 106 | 0.040 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2020 | 550 | 0.040 |
Why?
| Lipoproteins | 1 | 2016 | 39 | 0.030 |
Why?
| Mice, Inbred BALB C | 1 | 2016 | 296 | 0.030 |
Why?
| Neck | 1 | 2016 | 99 | 0.030 |
Why?
| Lipids | 1 | 2016 | 145 | 0.030 |
Why?
| Linear Models | 1 | 2016 | 274 | 0.030 |
Why?
| Isometric Contraction | 1 | 2014 | 21 | 0.030 |
Why?
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 17 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 48 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 49 | 0.030 |
Why?
| Torque | 1 | 2014 | 17 | 0.030 |
Why?
| Glucose Clamp Technique | 1 | 2014 | 15 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2016 | 579 | 0.030 |
Why?
| Calorimetry, Indirect | 1 | 2014 | 25 | 0.030 |
Why?
| Glucose Tolerance Test | 1 | 2014 | 56 | 0.030 |
Why?
| Basal Metabolism | 1 | 2014 | 31 | 0.030 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 96 | 0.030 |
Why?
| Anthropometry | 1 | 2014 | 91 | 0.030 |
Why?
| Demography | 1 | 2014 | 93 | 0.030 |
Why?
| Prognosis | 1 | 2019 | 1957 | 0.030 |
Why?
| Follow-Up Studies | 1 | 2019 | 2177 | 0.030 |
Why?
| Recovery of Function | 1 | 2014 | 187 | 0.030 |
Why?
| Survivors | 1 | 2014 | 120 | 0.030 |
Why?
| Radiopharmaceuticals | 1 | 2014 | 205 | 0.030 |
Why?
| Magnetic Resonance Imaging | 1 | 2020 | 1526 | 0.030 |
Why?
| Fluorodeoxyglucose F18 | 1 | 2014 | 191 | 0.030 |
Why?
| Ambulatory Care | 1 | 2014 | 221 | 0.030 |
Why?
| Reproducibility of Results | 2 | 2007 | 1182 | 0.030 |
Why?
| Metabolic Diseases | 1 | 2013 | 36 | 0.030 |
Why?
| Positron-Emission Tomography | 1 | 2014 | 288 | 0.030 |
Why?
| Leg | 2 | 2003 | 123 | 0.030 |
Why?
| Peroxisome Proliferator-Activated Receptors | 1 | 2012 | 14 | 0.020 |
Why?
| Hypolipidemic Agents | 1 | 2012 | 28 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2014 | 953 | 0.020 |
Why?
| Plasma Volume | 1 | 2009 | 4 | 0.020 |
Why?
| Capillary Permeability | 1 | 2009 | 35 | 0.020 |
Why?
| Tomography, X-Ray Computed | 1 | 2014 | 1153 | 0.020 |
Why?
| Radial Artery | 1 | 2009 | 29 | 0.020 |
Why?
| Tissue Distribution | 1 | 2009 | 163 | 0.020 |
Why?
| Veins | 1 | 2009 | 71 | 0.020 |
Why?
| Population | 1 | 2007 | 8 | 0.020 |
Why?
| Cardiac Output | 1 | 2007 | 46 | 0.020 |
Why?
| Hormones | 1 | 2007 | 57 | 0.020 |
Why?
| Coloring Agents | 1 | 2007 | 67 | 0.020 |
Why?
| Palmitoylcarnitine | 1 | 2005 | 6 | 0.020 |
Why?
| Methods | 1 | 2005 | 56 | 0.020 |
Why?
| Reference Standards | 1 | 2005 | 52 | 0.020 |
Why?
| Sex Characteristics | 1 | 2007 | 191 | 0.020 |
Why?
| Fluorocarbons | 1 | 2005 | 49 | 0.020 |
Why?
| Body Weight | 1 | 2007 | 512 | 0.020 |
Why?
| Rabbits | 1 | 2005 | 375 | 0.020 |
Why?
| Blood Pressure | 1 | 2007 | 519 | 0.010 |
Why?
| Granulocytes | 1 | 2004 | 26 | 0.010 |
Why?
| Albumins | 1 | 2004 | 30 | 0.010 |
Why?
| Task Performance and Analysis | 1 | 2004 | 52 | 0.010 |
Why?
| Blood Flow Velocity | 1 | 2002 | 100 | 0.010 |
Why?
| Valine | 1 | 2002 | 57 | 0.010 |
Why?
| Glycine | 1 | 2002 | 78 | 0.010 |
Why?
|
|
Borsheim's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|